Hendry R.G., Bilawchuk L.M., Marchant D.J. (2014) Tar-
geting matrix metalloproteinase activity and expression for the treatment
of viral myocarditis. J. Cardiovasc. Transl. Res., Vol. 7 (2): 212—215. doi:
10.1007/s12265–013–9528–2.
35.
Heymans S., Corsten M.F., Verhesen W. et al. (2013) Mac-
rophage microRNA-155 promotes cardiac hypertrophy and failure. Circu-
lation, Vol. 128: 1420 — 32. doi: 10.1161/CIRCULATIONAHA.112.001357.
36.
Heymans S., Eriksson U., Lehtonen J. et al. (2016) The
quest for new approaches in myocarditis and inflammatory cardiomy-
opathy. J. Am. Coll. Cardiol., Vol. 68(21): 2348–2364. doi: 10.1016/j.
jacc.2016.09.937.
37.
Hu J.R., Florido R., Lipson E.J. et al. (2019) Cardiovascular
toxicities associated with immune checkpoint inhibitors. Cardiovasc. Res.,
Vol. 115: 854–868. doi: 10.1093/cvr/cvz026.
38.
Hua X., Song J. (2019) Immune cell diversity contributes to the
pathogenesis of myocarditis. Heart Fail Rev., Vol. 24 (6): 1019–1030. doi:
10.1007/s10741–019–09799-w.
39.
Huber S.A. (2016) Viral myocarditis and dilated cardiomyopa-
thy: etiology and pathogenesis. Curr. Pharm. Des., Vol. 22(4): 408–426.
doi: 10.2174/1381612822666151222160500.
40.
Imanaka-Yoshida K. (2020) Inflammation in myocardial dis-
ease: From myocarditis to dilated cardiomyopathy. Pathology Interna-
tional., Vol. 1: 1–11. doi: 10.1111/pin.12868.
41.
Kasner M., Sinning D., Escher F. et al. (2013) The utility
of speckle tracking imaging in the diagnostic of acute myocarditis, as
proven by endomyocardial biopsy. Int. J. Cardiol., Vol. 168(3): 3023–
3024. doi: 10.1016/j.ijcard.2013.04.016.
42.
Kim M.J., Hong G.R., Ha J.W. et al. (2020) Acute Localized
Myocarditis: Role of Speckle Tracking Echocardiography. Korean Circ. J.,
Vol. 50(7): 638–640. doi: 10.4070/kcj.2019.0378.
43.
